Direct Rx has recalled two bottles of Zonisamide (100 mg capsules) due to quality control deviations in their microbiology laboratory. Zonisamide is a medication used to treat seizures in adults with epilepsy. This recall involves 30-count bottles distributed exclusively in Florida. No incidents or injuries have been reported in connection with this recall.
Deficiencies in the laboratory's quality control systems mean the manufacturer cannot guarantee the product's safety or sterility. While no specific illnesses have been reported, these gaps could potentially lead to products that do not meet required quality standards.
You have 2 options:
Packaged and Distributed By: Direct Rx Dawsonville, GA. Manufactured for Glenmark Pharmaceuticals Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.